Allarity Therapeutics, Inc. ("Allarity” or the "Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...

Mitsui O.S.K. Lines, Ltd (MOL) and Alt Carbon, a Carbon Dioxide Removal (CDR) company, announced a landmark deal to ...

Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge ...